Filing Details
- Accession Number:
- 0001593968-20-001570
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-02 16:03:11
- Reporting Period:
- 2020-07-01
- Accepted Time:
- 2020-07-02 16:03:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1771917 | Karuna Therapeutics Inc. | KRTX | Pharmaceutical Preparations (2834) | 270605902 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1777631 | K. Stephen Brannan | C/O Karuna Therapeutics, Inc. 33 Arch St Ste 3110 Boston MA 02110-1424 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-01 | 2,500 | $5.45 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-07-01 | 7,728 | $9.20 | 22,728 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-01 | 7,728 | $108.53 | 15,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2020-07-01 | 2,500 | $0.00 | 2,500 | $5.45 |
| Common Stock | Option (right to buy) | Disposition | 2020-07-01 | 7,728 | $0.00 | 7,728 | $9.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 58,829 | 2018-03-01 | 2027-06-02 | No | 4 | M | Direct |
| 75,445 | 2019-09-21 | 2029-03-21 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
